SEARCH

SEARCH BY CITATION

References

  • ASTON-JONES, G., SHIPLEY, M.T., CHOUVET, G., ENNIS, M., VAN BOCKSTAELE, E., PIERIBONE, V., SHIEKHATTAR, R., AKAOKA, H., DROLET, G. & ASTIER, B. (1991). Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog. Brain Res., 88, 4775.
  • BERNSTEIN, M.A. & WELCH, S.P. (1997). Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice. Drug Alcohol Depend., 44, 4146.
  • BILLAH, M.M. & ANTHES, J.C. (1990). The regulation and cellular functions of phosphatidylcholine hydrolysis. Biochem. J., 269, 281291.
  • BILSKY, E.J., BERNSTEIN, R.N., WANG, Z., SADEE, W. & PORRECA, F. (1996). Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance. J. Pharmacol. Exp. Therap., 277, 484490.
  • BLISS, C.I. (1967). Statistics in Biology, p. 439. New York: McGraw-Hill.
  • COLQUHOUN, D. (1971). Lectures in Biostatistics: An Introduction to Statistics With Applications in Biology and Medicine. London: Oxford Clarendon Press.
  • D'AMOUR, F.E. & SMITH, D.L. (1941). A method of determining loss of pain sensation. J. Pharmacol. Exp. Ther., 72, 7479.
  • DENNIS, E.A., RHEE, S.G., BILLAH, M.M. & HANNUN, Y.A. (1991). Role of phospholipases in generating lipid second messengers in signal transduction. FASEB J., 5, 20682077.
  • DEWEY, W.L., HARRIS, L.S., HOWES, J.F. & NUITE, J.A. (1970). The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther., 175, 435442.
  • FRIEL, D.D. & TSIEN, R.W. (1992). Phase-dependent contributions from Ca++ entry and Ca++ release to caffeine-induced [Ca++]i oscillations in bullfrog sympathetic neurons. Neuron, 8, 11091125.
  • FUNDYTUS, M.E. & CODERRE, T.J. (1996). Chronic inhibition of intracellular Ca++ release of protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol., 300, 173181.
  • FUNDYTUS, M.E., RITCHIE, J. & CODERRE, T.J. (1997). Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists. Br. J. Pharmacol., 120, 10151020.
  • HARRIS, L.S. & PIERSON, A.K. (1964). Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther., 143, 141148.
  • HASBI, A., POLASTRON, J., ALLOUCHE, S., STANASILA, L., MASSOTTE, D. & JAUZAC, P. (1998). Desensitization of the delta-opioid receptor correlates with its phosphorylation in SK-N-BE cells: involvement of a G protein-coupled receptor kinase. J. Neurochem., 70, 21292138.
  • HELFMAN, D.M., BARNES, K.C., KINKADE, J.M., VOGLER, W.R., SHOJI, M. & KUO, J.F. (1983). Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid. Cancer Res., 43, 29552961.
  • JONAS, S., SUGIMORI, M. & LLINAS, R. (1997). Low molecular weight heparin a neuroprotectant Ann. N.Y. Acad. Sci., 825, 389393.
  • KUNAPULI, P., ONORATO, J.J., HOSEY, M.M. & BENOVIC, J.L. (1994). Expression, purification, and characterizatioan of the G protein-coupled receptor kinase GRK5. J. Biol. Chem., 269, 10991105.
  • LAURI, S.E., KAUKINEN, S., KINNUNEN, T., YLINEN, A., IMAI, S., KAILA, K., TAIRA, T. & RAUVALA, H. (1999). Regulatory role and molecular interactions of a cell-surface heparin sulfate proteoglycan (N-syndecan) in hippocampal long-term potentiation. J. Neurosci., 19, 12261235.
  • MALMBERG, A.B., CHEN, C., TONEGAWA, S. & BASBAUM, A.I. (1997). Preserved acute pain and reduced neuropathic pain in mice lacking PKC-γ. Science, 278, 279283.
  • MAO, J., PRICE, D.D., PHILLIPS, L.L., LU, J. & MAYER, D.J. (1995). Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res., 677, 257267.
  • MORIKAWA, H., FUKUDA, K., MIMA, H., SHODA, T., KATO, S. & MORI, K. (1998). Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells. Br. J. Pharmacol., 123, 11111118.
  • NARITA, M., MAKIMURA, M., YANGZHENG, F., HOSKINS, B. & HO, I.K. (1994). Influence of chronic morphine treatment on protein kinase C activity comparison with butorphanol and implication for opioid tolerance. Brain Res., 650, 175179.
  • NARITA, M., MIZOGUCHI, H., KAMPINE, J.P. & TSENG, L.F. (1996). Role of protein kinase C in desentitization of spinal delta-opioid-mediated antinociception in the mouse. Br. J. Pharmacol., 118, 18291835.
  • NARITA, M., NARITA, M., MIZOGUCHI, H. & TSENG, L.F. (1995). Inhibition of protein kinase C, but not protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol., 280, R1R3.
  • NARITA, M., OHSAWA, M., MIZOGUCHI, H., KAMEI, J. & TSENG, L.F. (1997). Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse. Neuroscience, 76, 291298.
  • OHSAWA, M. & KAMEI, J. (1997). Possible involvement of protein kinase C in the attenuation of [D-Ala2, NMePhe4, Gly-ol5] enkephalin-induced antinociception in diabetic mice. Eur. J. Pharmacol., 339, 2731.
  • PATRICK, G.A., DEWEY, W.L., SPAULDING, T.C. & HARRIS, L.S. (1975). Relationship of brain morphine levels to analgesic activity in acutely treated mice and rats and in pellet-implanted mice. J. Pharmacol. Exp. Ther., 193, 876883.
  • PEDIGO, N.W., DEWEY, W.L. & HARRIS, L.S. (1975). Determination and characterization of the antinociceptive activity of intraventricularly administered acetylcholine in mice. J. Pharmacol. Exp. Ther., 193, 845852.
  • POWIS, G. & PHIL, D. (1994). Inhibitors of phosphatidylinositol signalling as antiproliferative agents. Cancer Metastasis Rev., 13, 91103.
  • REICHLING, D.B., KWIAT, G.C. & BASBAUM, A.I. (1988). Anatomy, physiology and pharmacology of the periaquiductal gray contribution to antinociceptive controls, In: Fields H.L. & Besson, J.M. (eds) Progress in Brain Research, pp. 3146. New York: Elsevier Science Publishers B.V. (Biomedical Division).
  • SMITH, F.L., DOMBROWSKI, D.S. & DEWEY, W.L. (1999). Involvement of intracellular calcium in morphine tolerance in mice. Pharmacol. Biochem. Behav., 62, 381388.
  • SMITH, F.L. & STEVENS, D.L. (1995). Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J. Pharmacol. Exp. Ther., 272, 290299.
  • SUAUDEAU, C., FLORIN, S., MEUNIER, J.C. & COSTENTIN, J. (1998). Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam. Clin. Pharmacol., 12, 420425.
  • TALLARIDA, R.J. & MURRAY, R.B. (1987). Manual of Pharmacologic Calculations with Computer Programs. Second Edition. pp. 2644. New York: Springer-Verlag.
  • VENTAYOL, P., BUSQUETS, X. & GARCIA-SEVILLA, J.A. (1997). Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 355, 491500.
  • ZHANG, J., FERGUSON, S.S., BARAK, L.S., BODDULURI, S.R., LAPORTE, S.A., LAW, P.Y. & CARON, M.G. (1998). Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U.S.A., 95, 71577162.
  • ZHANG, Z.X., LIAO, X.N., LI, X., CHEN, J. & WANG, C.X. (1992). The role of Ca++ in the analgesia induced by buprenorphine. Metal Ions Biol. Med., 2, 340342.